Detalhe da pesquisa
1.
Role of KCNK3 Dysfunction in Dasatinib-associated PAH and Endothelial Cell Dysfunction.
Am J Respir Cell Mol Biol
; 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38546978
2.
Characteristics and outcomes of patients developing pulmonary hypertension associated with proteasome inhibitors.
Eur Respir J
; 2024 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38697649
3.
Pulmonary vascular phenotype identified in patients with GDF2 (BMP9) or BMP10 variants: an international multicentre study.
Eur Respir J
; 63(4)2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38514094
4.
Orai1 Inhibitors as Potential Treatments for Pulmonary Arterial Hypertension.
Circ Res
; 131(9): e102-e119, 2022 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36164973
5.
Physiological and pathophysiological roles of the KCNK3 potassium channel in the pulmonary circulation and the heart.
J Physiol
; 601(17): 3717-3737, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37477289
6.
Contribution of transient receptor potential canonical channels in human and experimental pulmonary arterial hypertension.
Am J Physiol Lung Cell Mol Physiol
; 325(2): L246-L261, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37366608
7.
The p.E152K-STIM1 mutation deregulates Ca2+ signaling contributing to chronic pancreatitis.
J Cell Sci
; 134(3)2021 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33468626
8.
SUR1 As a New Therapeutic Target for Pulmonary Arterial Hypertension.
Am J Respir Cell Mol Biol
; 66(5): 539-554, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35175177
9.
Differential CFTR-Interactome Proximity Labeling Procedures Identify Enrichment in Multiple SLC Transporters.
Int J Mol Sci
; 23(16)2022 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36012204
10.
Orai1 Channel Inhibition Preserves Left Ventricular Systolic Function and Normal Ca2+ Handling After Pressure Overload.
Circulation
; 141(3): 199-216, 2020 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31906693
11.
Involvement of CFTR in the pathogenesis of pulmonary arterial hypertension.
Eur Respir J
; 58(5)2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33926975
12.
Characterization of Kcnk3-Mutated Rat, a Novel Model of Pulmonary Hypertension.
Circ Res
; 125(7): 678-695, 2019 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31347976
13.
Comparison of Human and Experimental Pulmonary Veno-Occlusive Disease.
Am J Respir Cell Mol Biol
; 63(1): 118-131, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32209028
14.
Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension.
Circulation
; 139(7): 932-948, 2019 02 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30586714
15.
In vivo miR-138-5p inhibition alleviates monocrotaline-induced pulmonary hypertension and normalizes pulmonary KCNK3 and SLC45A3 expression.
Respir Res
; 21(1): 186, 2020 Jul 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32678044
16.
Proteomic Analysis of KCNK3 Loss of Expression Identified Dysregulated Pathways in Pulmonary Vascular Cells.
Int J Mol Sci
; 21(19)2020 Oct 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33036472
17.
Therapeutic Potential of Sodium Houttuyfonate in Pulmonary Hypertension Through Orai-Ca2+ Channels.
Am J Respir Cell Mol Biol
; 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38749029
18.
Response to a Letter to the Editor: Physiological and pathophysiological roles of the KCNK3 potassium channel in the pulmonary circulation and the heart.
J Physiol
; 602(9): 2143-2144, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38648379
19.
NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.
Circulation
; 137(22): 2371-2389, 2018 05 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-29444988
20.
Functional interaction between PDGFß and GluN2B-containing NMDA receptors in smooth muscle cell proliferation and migration in pulmonary arterial hypertension.
Am J Physiol Lung Cell Mol Physiol
; 316(3): L445-L455, 2019 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30543306